Retrospective claims analysis of best supportive care costs and survival in a US metastatic renal cell population
Henry J Henk,1 Connie Chen,2 Agnes Benedict,3 Jane Sullivan,1 April Teitelbaum1 1Optum, Eden Prairie, MN, USA; 2Pfizer Inc, New York, NY, USA; 3United BioSource Corporation, London, UK Introduction: Survival and best supportive care (BSC) costs for patients with metastatic renal cell carcinoma (mRCC...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Livre |
| Publié: |
Dove Medical Press,
2013-07-01T00:00:00Z.
|
| Sujets: | |
| Accès en ligne: | Connect to this object online. |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Internet
Connect to this object online.3rd Floor Main Library
| Cote: |
A1234.567 |
|---|---|
| Exemplaire 1 | Disponible |